Navigation Links
Inaugural Herbert A. Fleisch ESCEO-IOF Medal is awarded to Professor Gerard Karsenty
Date:3/9/2011

The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF) have announced that Professor Gerard Karsenty of the Columbia University Medical Center is to be awarded the first Herbert A. Fleisch ESCEO-IOF Medal. Herbert Fleisch was a renowned researcher whose groundbreaking work contributed to the development of the field of scientific knowledge about metabolic bone diseases and their treatment.

The newly created award, valued at 20,000 Euro, recognizes a researcher who has made outstanding and groundbreaking achievements in basic bone science. The Medal will be presented on March 23rd at an award ceremony to take place at the opening of the European Congress on Osteoporosis & Osteoarthritis (ECCEO11-IOF), in Valencia, Spain.

Gerard Karsenty M.D., Ph.D., is Professor and Chair, Department of Genetics & Development, at the Columbia University Medical Center, New York. Professor Karsenty is renowned for his many fundamental contributions to understanding skeletal development and skeletal physiology. His laboratory has been instrumental in identifying Runx2 as the master gene of osteoblast differentiation and in deciphering the entire genetic cascade of osteoblast differentiation. He has contributed to the molecular elucidation of bone mineralization and has made significant advances in the study of bone physiology, based on the hypothesis he proposed that there must be a common control of bone mass, energy metabolism and reproduction. Testing this hypothesis revealed the existence of a central control of bone mass, a function regulated by leptin, a hormone appearing during evolution with bone cells and that inhibits both appetite and bone mass accrual. His laboratory then showed that bone is itself an endocrine organ producing an hormone, osteocalcin, that favors glucose homeostasis and male reproduction. Lastly Dr. Karsentys lab has shown that gut-derived serotonin is a powerful inhibitor of bone formation.

"Gerard Karsenty has been one of the most creative minds in the bone field, making exciting new findings that have furthered our understanding of skeletal physiology and the mechanisms of bone formation, said Professor Jean-Yves Reginster, President of ESCEO.

IOF President John Kanis went on to state, "This award, named in honour of a pioneer in osteoporosis research, appropriately recognizes an individual whose work has considerably influenced knowledge about bone and mineral metabolism."

Professor Karsenty has received a number of honours and awards, including the Lee C. Howley Prize for Arthritis Research in 2008. He is the Chair of the upcoming 1st IOF-ESCEO Pre-Clinical Symposium, to be held in Valencia from March 22-23, 2011.


'/>"/>

Contact: L. Misteli
info@iofbonehealth.org
International Osteoporosis Foundation
Source:Eurekalert

Related biology news :

1. International AIDS Society announces inaugural recipients of innovative HIV research awards
2. George Whitesides accepts inaugural Dreyfus Prize in the Chemical Sciences
3. George M. Whitesides receives inaugural Dreyfus prize in the chemical sciences
4. Easton honored with inaugural AACR Outstanding Investigator Award in Breast Cancer Research
5. Massague honored with inaugural AACR Distinguished Leadership Award in Breast Cancer Research
6. Penn presents inaugural symposium on applied mathematics and computational science
7. Dr. George Stark receives 2011 Herbert Tabor/Journal of Biological Chemistry Lectureship from ASBMB
8. Nobel laureate claims the 2010 Herbert Tabor Lectureship
9. ESCEO-IOF-ABBH Young Investigator Awards recognize research excellence
10. Genetic studies of human evolution win researcher 2011 Gani Medal
11. NIMHs Dr. Mortimer Mishkin to be awarded National Medal of Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
(Date:5/12/2016)... 2016 WearablesResearch.com , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
(Date:5/3/2016)...  Neurotechnology, a provider of high-precision biometric identification ... Identification System (ABIS) , a complete system for ... can process multiple complex biometric transactions with high ... face or iris biometrics. It leverages the core ... MegaMatcher Accelerator , which have been used in ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a company ... to the medical community, has closed its Series A ... Nunez . "We have received a commitment ... capital we need to meet our current goals," stated ... us the runway to complete validation on the current ...
(Date:6/23/2016)... Francisco, CA (PRWEB) , ... June 23, 2016 ... ... (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase its ... Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical ...
(Date:6/23/2016)... , June 22, 2016  Amgen (NASDAQ: ... of the QB3@953 life sciences incubator to ... health. The shared laboratory space at QB3@953 was created ... a key obstacle for many early stage organizations - ... of the sponsorship, Amgen launched two "Amgen Golden Ticket" ...
(Date:6/22/2016)... 22, 2016 Research and Markets has announced ... report to their offering. ... from $29.3 billion in 2013. The market is expected to grow ... 2015 to 2020, increasing from $50.6 billion in 2015 to $96.6 ... during the forecast period (2015 to 2020) are discussed. As well, ...
Breaking Biology Technology: